Rapid Dose Therapeutics Corp
CNSX:DOSE
Rapid Dose Therapeutics Corp
Research & Development
Rapid Dose Therapeutics Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Rapid Dose Therapeutics Corp
CNSX:DOSE
|
Research & Development
-CA$148.3k
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Research & Development
-CA$1.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
I
|
Imaging Dynamics Co Ltd
XTSX:IDL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Research & Development
-$764.5k
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
N
|
NuGen Medical Devices Inc
XTSX:NGMD
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Research & Development
-CA$9.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Rapid Dose Therapeutics Corp
Glance View
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.
See Also
What is Rapid Dose Therapeutics Corp's Research & Development?
Research & Development
-148.3k
CAD
Based on the financial report for Feb 28, 2025, Rapid Dose Therapeutics Corp's Research & Development amounts to -148.3k CAD.
What is Rapid Dose Therapeutics Corp's Research & Development growth rate?
Research & Development CAGR 5Y
11%
Over the last year, the Research & Development growth was 65%. The average annual Research & Development growth rates for Rapid Dose Therapeutics Corp have been 26% over the past three years , 11% over the past five years .
